L&K Biomed Ltd. (KOSDAQ:156100)

South Korea flag South Korea · Delayed Price · Currency is KRW
11,600
-40 (-0.34%)
At close: Feb 27, 2026
63.38%
Market Cap 259.27B
Revenue (ttm) 40.33B
Net Income (ttm) 5.84B
Shares Out 22.35M
EPS (ttm) 265.47
PE Ratio 43.70
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 464,790
Average Volume 369,405
Open 11,850
Previous Close 11,640
Day's Range 11,490 - 12,180
52-Week Range 5,570 - 16,400
Beta 0.85
RSI 34.19
Earnings Date Mar 12, 2026

About L&K Biomed

L&K Biomed Ltd., a medical company, manufactures and sells spinal implants in South Korea, the United States, Thailand, and internationally. The company offers spinal products comprising BlueEX-T, BluEX-TC, BluEX-A, BlueEX-L, and BluEX-ATP; BluEX-LT, an advanced lateral cage system for spinal lordosis restoration; PathLoc-TM, an expandable TLIF/PLIF lumbar cage system; AccelFix-XL, an expandable lateral lumbar cage system; AccelFix-XTP, an expandable lumbar cage system for anterior-to-psoas approach; and PathLoc-TA, an expandable ALIF anterior ... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 2008
Employees 101
Stock Exchange KOSDAQ
Ticker Symbol 156100
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.